Taxis 2021-05: Study Taxis 2021-05: Efficacy Study of YZZ-9-155 in combination with ceftazidime in murine lung infection model

Project Details

StatusFinished
Effective start/end date13/05/21 → 31/12/21

Funding

  • TAXIS Pharmaceuticals, Inc.: $19,364.00

Keywords

  • Biotechnology & Drug Development, Infectious Diseases